FDA Approves New Treatment for Alzheimer Disease

Today the Food and Drug Administration (FDA) approved a biologics license application (BLA) for Aduhelm (aducanumab; Biogen) for the treatment of Alzheimer disease. Aduhelm is an amyloid beta-directed antibody that is administered via intravenous infusion every 4...